Qianhai Health Holdings Limited (Stock Code: 911) has announced that, based on preliminary assessments of unaudited consolidated management accounts for the year ended 31 December 2025, the Group anticipates a net profit attributable to shareholders of about HK$5.00 million to HK$6.00 million. This range compares with the previous year’s figure of approximately HK$1.30 million.

The Company attributes the improved consolidated net profit primarily to the absence of any provision for onerous contracts for the reporting period. The financial details remain subject to potential adjustments and audit review.

The final annual results announcement is expected to be published in March 2026. Shareholders and potential investors are advised to exercise caution when trading the Company’s shares.